AssetMark Inc’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,058
Closed -$1.98M 1681
2022
Q3
$1.98M Buy
8,058
+1,859
+30% +$502K 0.01% 390
2022
Q2
$1.53M Buy
6,199
+2,673
+76% +$721K 0.01% 409
2022
Q1
$1.17M Buy
3,526
+2,310
+190% +$711K ﹤0.01% 438
2021
Q4
$437K Buy
1,216
+1,209
+17,271% +$408K ﹤0.01% 566
2021
Q3
$2K Buy
+7
New +$2.37K ﹤0.01% 1297
2020
Q2
Sell
-13
Closed -$2K 1476
2020
Q1
$2K Sell
13
-436
-97% -$72.4K ﹤0.01% 1220
2019
Q4
$77K Buy
449
+44
+11% +$8.16K ﹤0.01% 665
2019
Q3
$72K Buy
405
+73
+22% +$15.8K ﹤0.01% 659
2019
Q2
$86K Sell
332
-41
-11% -$10.9K ﹤0.01% 631
2019
Q1
$107K Sell
373
-18
-5% -$5.98K ﹤0.01% 562
2018
Q4
$127K Buy
391
+319
+443% +$111K ﹤0.01% 516
2018
Q3
$32K Hold
72
﹤0.01% 836
2018
Q2
$29K Sell
72
-4
-5% -$1.45K ﹤0.01% 843
2018
Q1
$22K Buy
76
+26
+52% +$6.59K ﹤0.01% 925
2017
Q4
$9K Buy
50
+5
+11% +$934 ﹤0.01% 1140
2017
Q3
$8K Buy
+45
New +$6.8K ﹤0.01% 1074
2016
Q2
Sell
-331
Closed -$31K 1292
2016
Q1
$31K Sell
331
-518
-61% -$43.7K ﹤0.01% 681
2015
Q4
$77K Buy
+849
New +$72K ﹤0.01% 534

Other funds holding ABMD

AssetMark Inc's ABMD Position: Q4 2022 in Review

AssetMark Inc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,058 shares — an estimated $1.98M sold.

AssetMark Inc first reported a position in ABMD in Q4 2015 and held it in 18 quarters. The position peaked at $1.98M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • AssetMark Inc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • AssetMark Inc sold 8,058 Abiomed Inc shares in Q4 2022, an estimated $1.98M.
  • AssetMark Inc first reported a position in Abiomed Inc in Q4 2015 and held it in 18 quarters.
  • AssetMark Inc's Abiomed Inc position peaked at $1.98M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AssetMark Inc's 13F filing for Q4 2022, filed 10 Feb 2023.